Financial reports
Current reports
8-K
Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company
24 Jan 24
8-K
Bowen Acquisition Corp
15 Aug 23
8-K
Bowen Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
14 Aug 23
8-K
Bowen Acquisition Corp
20 Jul 23
8-K
Bowen Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
14 Jul 23
Registration and prospectus
Proxies
No filings
Ownership
SC 13D
Createcharm Holdings Ltd
15 Feb 24
SC 13D
Bowen Holding LP
15 Feb 24
SC 13G
PERISCOPE CAPITAL INC.
9 Feb 24
SC 13G
Bulldog Investors, LLP
1 Feb 24
SC 13G/A
Harraden Circle Investments, LLC
31 Jan 24
SC 13G
SPRING CREEK CAPITAL LLC
19 Sep 23
SC 13G
Harraden Circle Investments, LLC
18 Jul 23
3
Jun Zhang
11 Jul 23
3
Wei Li
11 Jul 23
3
Lawrence W. Leighton
11 Jul 23